600055 Beijing Wandong Medical Technology
- 14.58
- 0.000.00%
Beijing Wandong Medical Technology News
Wandong Medical (600055.SH) will distribute the 2023 cash dividend of 0.13 yuan per share on May 17
Zhitong Finance App News, Wandong Healthcare (600055.SH) announced that the company will pay the 2023 annual cash dividend of 0.13 yuan (tax included) per share on May 17, 2024. The share registration date for this equity distribution is May 16, 2024, and the exclusion (interest) date is May 17, 2024.
Wandong Medical (600055.SH) announced first-quarter results, net profit of 33.26 million yuan, up 9.26% year on year
According to the Zhitong Finance App, Wandong Medical (600055.SH) disclosed its report for the first quarter of 2024. During the reporting period, the company achieved revenue of 308 million yuan, an increase of 20.94% year on year; net profit to mother was 33.26 million yuan, up 9.26% year on year; after deducting non-net profit of 31.35 million yuan, an increase of 7.06% year on year. Basic earnings per share were $0.04.
Wandong Medical (600055.SH): Net profit increased 7.51% year-on-year in 2023, and plans to distribute 10 to 1.30 yuan
On March 22, Ge Longhui (600055.SH) released its 2023 annual report. During the reporting period, it achieved operating income of 1,237 billion yuan, an increase of 10.30%; net profit attributable to shareholders of listed companies was 189 million yuan, up 7.51% year on year; net profit attributable to shareholders of listed companies after deducting non-recurring profit and loss was 136 million yuan, down 13.32% year on year; and basic earnings per share were 0.269 yuan. The 2023 profit distribution plan is based on a total share capital of 703,061,058 shares, with a cash dividend of 1.30 yuan (tax included) for every 10 shares.
Wandong Medical (600055.SH): There are no plans to develop CT tubes or CT generators
Gelonghui, January 16丨Wandong Medical (600055.SH) said on an interactive platform that currently the company is involved in imported components of CT systems such as CT tubes, CT generators, etc., and the company has no plans to develop CT tubes or CT generators.
Wandong Medical (600055.SH): Currently developing advanced clinical functions of magnetic resonance according to the plan
Gelonghui, January 16丨Wandong Medical (600055.SH) said on an interactive platform that the company is currently developing advanced clinical functions of magnetic resonance according to the plan.
Wandong Medical (600055.SH): Currently no 128-row CT has been developed
Gelonghui, December 27丨Wandong Medical (600055.SH) said on an interactive platform that the 3.0T and suspension DSA are being developed according to the plan and will be announced promptly after the registration certificate is officially obtained; the company is not currently developing a 128-row CT.
Wandong Healthcare (600055.SH) appoints Song Jinsong as president
Wandong Medical (600055.SH) issued an announcement. The company's board of directors recently received Xie Yufeng, the company's director and president...
Wandong Healthcare (600055.SH) plans to spend 100 million yuan to set up a wholly-owned subsidiary in Suzhou
Wandong Medical (600055.SH) announced that according to the needs of the company's strategic development layout, it will make full use of local policies and...
Wandong Medical (600055.SH)'s net profit for the third quarter was 44,142 million yuan, up 0.75% year on year
On October 27, Gelonghui (600055.SH) released its report for the third quarter of 2023. From July to September 2023, operating income was 331 million yuan, up 20.04% year on year; net profit attributable to shareholders of listed companies was 44,142 million yuan, up 0.75% year on year; net profit attributable to shareholders of listed companies after deducting non-recurring profit and loss was 34.79 million yuan, down 13.29% year on year, basic earnings per share of 0.063 yuan
Wandong Medical (600055.SH) released semi-annual results, net profit of 76.04 million yuan, an increase of 28.21% over the previous year
Wandong Medical (600055.SH) disclosed the 2023 semi-annual report. The company achieved revenue of 5.94 during the reporting period...
Midea Group (000333.SZ): Wandong Medical has made breakthroughs in product lines such as high-end DR, liquid-free helium-free superconducting MRI, high-emission CT, and high-power mobile DR
GLONGHUI August 15丨Some investors asked Midea Group (000333.SZ), “For high-end medical imaging products, it is recommended to use the Midea trademark. Open up the market.” Midea Group replied that Wandong Medical is a large-scale medical imaging equipment company integrating R&D, manufacturing, sales and after-sales service. Wandong Medical formulated a three-year R&D plan and continued to increase R&D personnel recruitment and R&D investment. In 2022, Wandong Medical added 42 new R&D personnel, spent 138 million yuan on R&D, and increased the proportion of R&D expenses to 12.29%. Wandong Medical is doing high-end DR, liquid-free helium-free superconducting MRI, high-emission CT, and high
Zhongtai Securities: “14th Five-Year Plan” Large-scale Medical Equipment Configuration Plan Released, Focusing on Opportunities to Accelerate Release of High-end Equipment
The Zhitong Finance App learned that Zhongtai Securities released a research report saying that the “14th Five-Year Plan” deployment plan is expected to drive the expansion of the high-end medical equipment market and stimulate the procurement needs of medical institutions, especially middle and primary medical institutions. Related equipment companies are expected to experience an acceleration in performance. The bank expects leading domestic companies with advanced product performance, extensive channel layout, and strong R&D capabilities to be the first to benefit, such as Lianying Medical (688271.SH), Wandong Medical (600055.SH), Minimally Invasive Robot-B (02252), etc. It also suggests paying attention to leading private medical institutions, such as Haijia Healthcare (06078),
Midea's full acquisition of Kuka! What is the meaning of the layout robot of "Brother Baidian"?
"if you want to do good work, you must first sharpen its tools." In the capital market, if listed companies want a "sharp tool", it is inevitable to spend money on investment. On the other hand, if a listed company spends a lot of money, it can also get a glimpse of the business that the company intends to do. Recently, Midea's trend explains this point of view. On the evening of November 23rd, Midea announced that the company plans to fully acquire and privatize the shares of KUKA Aktiengesellschaft, a company listed on the Frankfurt Stock Exchange of Germany (referred to as Kuka), through its wholly-owned subsidiaries. Retrospective 2
Graphic illustration of Wandong Medical's three-quarter report: net profit in the third quarter decreased by 13.41% compared with the same period last year.
According to the third quarterly report of Wandong Medical in 2021, the company's main income was 801 million yuan, up 8.75% from the same period last year; the net profit was 120 million yuan, down 18.73% from the same period last year; and the non-net profit was 109 million yuan, down 21.08% from the same period last year. Among them, in the third quarter of 2021, the company's main income in a single quarter was 306 million yuan, up 31.13% from the same period last year; and the net profit in a single quarter was 37.1017 million yuan, down 13.41% from the same period last year. The non-net profit in a single quarter was 36.5496 million yuan, down 7.16% from the same period last year; the debt ratio was 13.13%, and the investment income was 12.6552 million.
The latest announcement of Wandong Medical: net profit in the third quarter fell by 13.41% to 37.1017 million yuan.
Wandong Medical released a report for the third quarter of 2021 that the company realized operating income of 306 million yuan, an increase of 31.13% over the same period last year. Net profit belonging to shareholders of listed companies was 37.1017 million yuan, down 13.41% from the same period last year. Net profit belonging to shareholders of listed companies after deducting non-recurring gains and losses was 36.5496 million yuan, down 7.16% from the same period last year; and basic earnings per share was 0.069 yuan. According to the 2021 report of Wandong Medical, the company's main income was 495 million yuan, down 1.63% from the same period last year; the net profit from its mother was 83.2103 million yuan, down 20.9% from the same period last year; deducting 7% from non-net profit
Analysis
Price Target
No Data
